IPO Boutique

Braeburn Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Braeburn Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Braeburn PharmaceuticalsBBRX -
NASDAQ
TBD $0.00 $0.00TBD
J.P. Morgan, BofA Merrill Lynch, Deutsche Bank Securities
Co-Manager(s):
Canaccord Genuity
Filing(s):

Filed 2016-12-30
Terms Added 2017-01-18



About Braeburn Pharmaceuticals (adapted from Braeburn Pharmaceuticals prospectus):
They are a commercial-stage pharmaceutical company focused on the development and commercialization of novel long-acting medications for serious disorders of the central nervous system, or CNS.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "BBRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved